Gyu Tae Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gyu Tae Park has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jeong Hoon Yang
Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Woo Jin Jang
Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea
2 shared publications - Hyeon-Cheol Gwon
Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication Ik Hyun Park
Department of Cardiology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
1 shared publication- Ik Hyun Park
Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea (I.H.P.).
1 shared publication - Joonhwa Hong
Department of Thoracic and Cardiovascular Surgery, Chung‐Ang University Hospital Chung‐Ang University College of Medicine Seoul South Korea
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Forty-Eight Hour Lactate Normalization Predicts Favorable Neurologic Recovery and Survival in Venoarterial ECMO for Cardiogenic Shock
Extracorporeal membrane oxygenation (ECMO) for cardiogenic shock (CS) is associated with high mortality and poor neurological outcomes. Dynamic assessment of metabolic recovery, reflected by lactate normalization, may offer additional prognostic value compared with static severity indices. We retrospectively analyzed 662 consecutive patients from the multicenter RESCUE II registry who remained on venoarterial ECMO for at least 48 hours. Patients were stratified by 48 hour lactate level: 48 hour lactate normalization group (< 2.0 mmol/L, n = 371) and persistent lactate elevation group (≥ 2.0 mmol/L, n = 291). The primary outcome was favorable neurologic discharge (FND), defined as discharge with a Cerebral Performance Category score of 1 or 2. The persistent lactate elevation group had a higher SOFA score (9.8 ± 3.2 vs . 8.5 ± 3.4, p < 0.001) and initial serum lactate (7.9 ± 4.8 mmol/L vs. 6.0 ± 4.3 mmol/L, p < 0.001). Lactate normalization was associated with a higher rate of FND (71.4% vs . 41.9%, p < 0.001), remained an independent predictor of FND (odds ratio [OR]: 3.12, 95% confidence interval [CI]: 2.21–4.41, p < 0.001), and was associated with lower risks of all-cause death (hazard ratio [HR]: 0.49, 95% CI: 0.38–0.64, p < 0.001) at 12 months. In conclusion, lactate normalization within 48 hours of ECMO initiation is associated with favorable neurologic status and 12 month survival.
- 13 October 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Open AccessForty-Eight Hour Lactate Normalization Predicts Favorable Neurologic Recovery and Survival in Venoarterial ECMO for Cardiogenic Shock
Extracorporeal membrane oxygenation (ECMO) for cardiogenic shock (CS) is associated with high mortality and poor neurological outcomes. Dynamic assessment of metabolic recovery, reflected by lactate normalization, may offer additional prognostic value compared with static severity indices. We retrospectively analyzed 662 consecutive patients from the multicenter RESCUE II registry who remained on venoarterial ECMO for at least 48 hours. Patients were stratified by 48 hour lactate level: 48 hour lactate normalization group (< 2.0 mmol/L, n = 371) and persistent lactate elevation group (≥ 2.0 mmol/L, n = 291). The primary outcome was favorable neurologic discharge (FND), defined as discharge with a Cerebral Performance Category score of 1 or 2. The persistent lactate elevation group had a higher SOFA score (9.8 ± 3.2 vs . 8.5 ± 3.4, p < 0.001) and initial serum lactate (7.9 ± 4.8 mmol/L vs. 6.0 ± 4.3 mmol/L, p < 0.001). Lactate normalization was associated with a higher rate of FND (71.4% vs . 41.9%, p < 0.001), remained an independent predictor of FND (odds ratio [OR]: 3.12, 95% confidence interval [CI]: 2.21–4.41, p < 0.001), and was associated with lower risks of all-cause death (hazard ratio [HR]: 0.49, 95% CI: 0.38–0.64, p < 0.001) at 12 months. In conclusion, lactate normalization within 48 hours of ECMO initiation is associated with favorable neurologic status and 12 month survival.
- Open Access
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 506-514
Venoarterial extracorporeal membrane oxygenation as a rescue strategy in high-risk pulmonary thromboembolism
Acute high-risk pulmonary thromboembolism (PTE) is the most severe clinical manifestation of venous thromboembolism, carrying a substantial mortality rate, particularly when complicated by cardiogenic shock or cardiac arrest. Although current guidelines recommend systemic thrombolysis for high-risk PTE in the absence of contraindications, this approach is associated with a significant risk of major hemorrhage and may be precluded in patients with severe comorbidities, advanced frailty, or elevated perioperative risk. Consequently, venoarterial extracorporeal membrane oxygenation (VA-ECMO) has emerged as an important mechanical circulatory support strategy for this vulnerable cohort. By bypassing the obstructed pulmonary vascular bed, VA-ECMO facilitates rapid hemodynamic stabilization, mechanically unloads the strained right ventricle, and reverses systemic hypoperfusion. This review elucidates the pathophysiological rationale for right ventricular unloading in high-risk PTE and examines the evolving approach toward catheter-directed interventions and patient-tailored treatment strategies. Furthermore, we evaluate the clinical outcomes of VA-ECMO when deployed either as a stand-alone therapy bridge to recovery alongside systemic anticoagulation or as a bridge to definitive active thrombus clearance.
- 31 August 2026
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 41 (3) , 506-514
Open AccessVenoarterial extracorporeal membrane oxygenation as a rescue strategy in high-risk pulmonary thromboembolism
Acute high-risk pulmonary thromboembolism (PTE) is the most severe clinical manifestation of venous thromboembolism, carrying a substantial mortality rate, particularly when complicated by cardiogenic shock or cardiac arrest. Although current guidelines recommend systemic thrombolysis for high-risk PTE in the absence of contraindications, this approach is associated with a significant risk of major hemorrhage and may be precluded in patients with severe comorbidities, advanced frailty, or elevated perioperative risk. Consequently, venoarterial extracorporeal membrane oxygenation (VA-ECMO) has emerged as an important mechanical circulatory support strategy for this vulnerable cohort. By bypassing the obstructed pulmonary vascular bed, VA-ECMO facilitates rapid hemodynamic stabilization, mechanically unloads the strained right ventricle, and reverses systemic hypoperfusion. This review elucidates the pathophysiological rationale for right ventricular unloading in high-risk PTE and examines the evolving approach toward catheter-directed interventions and patient-tailored treatment strategies. Furthermore, we evaluate the clinical outcomes of VA-ECMO when deployed either as a stand-alone therapy bridge to recovery alongside systemic anticoagulation or as a bridge to definitive active thrombus clearance.
- Open Access
- 25 June 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Safety and feasibility of a single-surgeon cardiac surgery program during workforce shortage: a propensity-matched cohort study
This study compared clinical outcomes of cardiac surgeries performed by a single surgeon (operating alone [OA]) versus those performed by multiple surgeons (operating together [OT]) to evaluate the feasibility and safety of different surgical staffing models. We retrospectively reviewed adult patients who underwent cardiac surgery at Chung-Ang University Hospital from September 2016 to August 2021. Between September 2016 and August 2018, two or three surgeons assisted each other (OT), while from September 2018 to August 2021, a single surgeon operated alone (OA). After propensity score matching, 79 patients were selected in each group for analysis. Major postoperative adverse events, including mortality, stroke, new-onset atrial fibrillation, and low cardiac output, did not statistically significant differ between groups. Other postoperative outcomes such as, acute kidney injury, ICU stay length, hospital days, CPB time, ACC time was not statistically different, whereas operation time was shorter in the OT group than in the OA group (median 300 vs. 379 min, P < 0.001). Except for differences in operation time, there were not significantly different short-term postoperative outcomes in OT and OA groups. Given the various limitations of the present study, the result should be interpreted cautiously.
- 25 June 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessSafety and feasibility of a single-surgeon cardiac surgery program during workforce shortage: a propensity-matched cohort study
This study compared clinical outcomes of cardiac surgeries performed by a single surgeon (operating alone [OA]) versus those performed by multiple surgeons (operating together [OT]) to evaluate the feasibility and safety of different surgical staffing models. We retrospectively reviewed adult patients who underwent cardiac surgery at Chung-Ang University Hospital from September 2016 to August 2021. Between September 2016 and August 2018, two or three surgeons assisted each other (OT), while from September 2018 to August 2021, a single surgeon operated alone (OA). After propensity score matching, 79 patients were selected in each group for analysis. Major postoperative adverse events, including mortality, stroke, new-onset atrial fibrillation, and low cardiac output, did not statistically significant differ between groups. Other postoperative outcomes such as, acute kidney injury, ICU stay length, hospital days, CPB time, ACC time was not statistically different, whereas operation time was shorter in the OT group than in the OA group (median 300 vs. 379 min, P < 0.001). Except for differences in operation time, there were not significantly different short-term postoperative outcomes in OT and OA groups. Given the various limitations of the present study, the result should be interpreted cautiously.